The President's Cancer Panel urges improvements in value frameworks and expanded insurance coverage as ways to better align prices with value and enhance the affordability of cancer drugs in a report released March 13.
Entitled "Promoting Value, Affordability and Innovation in Cancer Drug Treatment," the report offers six recommendations that align with biopharma industry...






